Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Crown Equity Holdings, Inc. (CRWE) Message Board

Intercept Pharmaceuticals (ICPT) Soars On 2014 Anticipated Milestones

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 24
Posted On: 01/10/2014 11:40:42 AM
Posted By: riddock57

http://pennyomega.com/img/icpt.jpg Intercept Pharmaceuticals, Inc. (ICPT)


Shares of ICPT are trading on different levels after the company provided a clinical update on obeticholic acid, a novel bile acid analog and first-in-class agonist of the farnesoid X receptor, currently being developed in a Phase 3 trial for primary biliary cirrhosis, as well as Phase 2 trials for several chronic indications including nonalcoholic steatohepatitis, portal hypertension and bile acid diarrhea, together with projected 2014 anticipated milestones.


ICPT 's price target was raised:


- from $270.00 to $375.00 by brokerage firm BMO Capital


- from $94.00 to $360.00 by brokerage firm Oppenheimer


- from $60.00 to $400.00 by brokerage firm Citigroup


- from $81.00 to $872.00 by brokerage firm BofA/Merrill


http://pennyomega.com/img/icpt_chart.png


ICPT is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat orphan and more prevalent liver diseases utilizing its expertise in bile acid chemistry.


ICPT 's lead product candidate, obeticholic acid, has received orphan drug designation in both the United States and Europe for the treatment of primary biliary cirrhosis. ICPT owns worldwide rights to obeticholic acid outside of Japan and China, where it has out-licensed the product candidate to Dainippon Sumitomo Pharma.


More about Intercept Pharmaceuticals, Inc. (ICPT) at www.interceptpharma.com .


**


http://pennyomega.com/img/crwe_logo.jpg Crown Equity Holdings Inc. (CRWE)


Social networking is based on a certain structure that allow people to both express their individuality and meet people with similar interests. This structure includes having profiles, friends, blog posts, widgets, and usually something unique to that particular social networking website.


CRWE is looking to deliver value for its stockholders in both the near and long term, targeting the multi-billion dollar social networking service market.


CRWE is currently developing a social networking service and phone app, CRWE Network ( CRWE-PR.com ), that is designed to target all the communities in every state of the United States, with its geographic focus starting in Southern California and Las Vegas Nevada.


CRWE_Network


CRWE ‘s business plan is based on selling advertising to local businesses. Its goal is to facilitate exchanges of goods and services in a manner similar to Craigslist, a classified advertisements website with sections devoted to jobs, housing, personals, for sale, items wanted, services, community, gigs, résumés, and discussion forums.


CRWE offers advertising branding and marketing services as a worldwide online multi-media publisher.


More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com .


**


Read Full Disclaimer at www.pennyomega.com/disclaimer



(0)
(0)




Crown Equity Holdings, Inc. (CRWE) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us